SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HELIX BIOPHARMA (HBP:TSE) -- Ignore unavailable to you. Want to Upgrade?


To: thewiz who wrote (173)3/4/1999 4:05:00 PM
From: burner  Read Replies (1) | Respond to of 193
 
Helix subsidiary appoints new board member

Helix Biopharma Corp HBP
Shares issued 13,776,415 Mar 3 close $0.38
Thu 4 Mar 99 News Release
An anonymous director reports
Dr. Paul M. Russo, chairman, CEO and co-founder of Genesis Microchip Inc.
has been appointed to the board of directors of the company's subsidiary,
Sensium Technologies Inc.
Sensium was established to develop a miniaturized, self-contained biosensor
based on its proprietary molecular sensing technology. Applications for
this technology include medical diagnostics, food contaminant detection and
environmental testing.
Sensium has also received an additional $250,000 investment commitment to
bring the total minority investment to $1-million.
GNSS:NASDAQ